AbbVie, Inc.AbbVie, Inc.AbbVie, Inc.

AbbVie, Inc.

Keine Trades

Unternehmensanleihen

Unten befindet sich eine Liste der AbbVie, Inc.-Anleihen, sortiert nach Ihrer Rendite bis zum Laufzeitende. Anleger entscheiden sich oft für die Anleihen eines Unternehmens, weil sie eine gesteigerte Stabilität zu Zeiten einer Marktvolatilität bieten. Analysieren Sie die Preise, Renditen und weitere Daten, um eine zuverlässige Investition zu entdecken.
Symbol
YTM %
Volumen
Preis %
Coupon %
Verfallsdatum
Ausstehend
Nennwert
Min. Anlagebetrag
Emittent
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
7,00%26 K76,04%4,750%2045-03-1553,51 M USD1.000,00 USD2.000,00 USD
Allergan Funding SCS
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
6,40%12 K83,25%4,850%2044-06-1565,23 M USD1.000,00 USD2.000,00 USD
Allergan Funding SCS
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
6,38%124 K81,98%4,625%2042-10-0167,49 M USD1.000,00 USD2.000,00 USD
Actavis, Inc.
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
5,79%250 K91,22%4,550%2035-03-15107,65 M USD1.000,00 USD2.000,00 USD
Allergan Funding SCS
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5,70%2,21 M96,77%5,500%2064-03-151,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5,62%24,81 M97,08%5,400%2054-03-153 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV6009613AbbVie Inc. 5.6% 15-MAR-2055
5,59%7,57 M100,14%5,600%2055-03-15750 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAW9AbbVie Inc. 4.45% 14-MAY-2046
5,57%086,40%4,450%2046-05-142 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
5,56%3,38 M82,72%4,250%2049-11-215,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
5,55%12,2 M91,10%4,875%2048-11-141,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABBAbbVie Inc. 4.7% 14-MAY-2045
5,53%090,14%4,700%2045-05-142,7 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5,49%26 K90,47%3,200%2029-11-2162,52 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
5,48%65 K91,35%4,750%2045-03-15827,09 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
5,48%2,53 M92,76%4,850%2044-06-151,01 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
5,45%3,9 M99,00%5,350%2044-03-15750 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US00287YAM12AbbVie Inc. 4.4% 06-NOV-2042
5,40%088,99%4,400%2042-11-062,6 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
5,40%376 K91,68%4,625%2042-10-01389,22 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
5,14%3,45 M89,24%4,050%2039-11-214 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAV1AbbVie Inc. 4.3% 14-MAY-2036
4,86%095,50%4,300%2036-05-141 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAR0AbbVie Inc. 4.5% 14-MAY-2035
4,77%097,95%4,500%2035-05-142,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV6009165AbbVie Inc. 5.2% 15-MAR-2035
4,74%4,42 M103,42%5,200%2035-03-151 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
4,73%14,19 M98,65%4,550%2035-03-151,68 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
4,63%5,54 M102,83%5,050%2034-03-153 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4,18%3,13 M103,48%4,950%2031-03-152 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
4,06%8,01 M97,24%3,200%2029-11-215,44 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV6009612AbbVie Inc. 4.875% 15-MAR-2030
4,04%1,41 M103,20%4,875%2030-03-151 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAY5AbbVie Inc. 3.2% 14-MAY-2026
3,90%099,82%3,200%2026-05-142 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
3,90%3,63 M102,64%4,800%2029-03-152,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
3,79%9,89 M101,16%4,250%2028-11-141,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
3,78%1,12 M101,14%4,800%2027-03-152,25 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV6009611AbbVie Inc. 4.65% 15-MAR-2028
3,76%411 K101,79%4,650%2028-03-151,25 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
3,75%12,79 M99,37%2,950%2026-11-213,99 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
XS190919331Allergan Funding SCS 2.625% 15-NOV-2028
3,69%097,24%2,625%2028-11-1572,11 M EUR1.000,00 EUR100.000,00 EUR
Allergan Funding SCS
XXS162262122Allergan Funding SCS 2.125% 01-JUN-2029
3,59%095,48%2,125%2029-06-0136,46 M EUR1.000,00 EUR100.000,00 EUR
Allergan Funding SCS
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
3,16%0126,76%4,750%2045-03-155 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
3,13%0128,71%4,850%2044-06-15100 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
3,13%0121,31%4,250%2049-11-214,95 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABGAbbVie Inc. 1.25% 18-NOV-2031
2,98%090,94%1,250%2031-11-18650 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS212591491AbbVie Inc. 2.125% 01-JUN-2029
2,60%098,51%2,125%2029-06-01506,09 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS152090781AbbVie Inc. 2.125% 17-NOV-2028
2,58%098,79%2,125%2028-11-17750 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2,57%0123,74%4,550%2035-03-151 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
XS212591483AbbVie Inc. 2.625% 15-NOV-2028
2,49%0100,35%2,625%2028-11-15427,79 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
4ABEAbbVie Inc. 0.75% 18-NOV-2027
2,39%097,17%0,750%2027-11-18750 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
−5,92%098,80%2,950%2026-11-219,24 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
4,400%2042-11-061,1 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.